Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,248 | 3,911 | 8,659 | 8,513 | 4,127 |
| Gross Profit | 1,248 | 3,911 | 8,659 | 8,513 | 4,127 |
| Operating Expenses | 25,835 | 28,278 | 31,498 | 29,500 | 31,947 |
| Operating Income | -24,587 | -24,367 | -22,839 | -20,987 | -27,820 |
| Other Income | 1,538 | 1,873 | 2,212 | 1,123 | 2,879 |
| Pre-tax Income | -23,049 | -22,494 | -20,627 | -19,864 | -24,941 |
| Income Tax | 10 | 34 | -234 | 44 | 98 |
| Net Income Continuous | -23,059 | -22,528 | -20,393 | -19,908 | -25,039 |
| Net Income | $-23,059 | $-22,528 | $-20,393 | $-19,908 | $-25,039 |
| EPS Basic Total Ops | -0.61 | -0.59 | -0.55 | -0.54 | -0.68 |
| EPS Basic Continuous Ops | -0.61 | -0.60 | -0.55 | -0.54 | -0.68 |
| EPS Diluted Total Ops | -0.61 | -0.59 | -0.55 | -0.54 | -0.68 |
| EPS Diluted Continuous Ops | -0.61 | -0.60 | -0.55 | -0.54 | -0.68 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.60 | -0.55 | -0.54 | -0.68 |
| EBITDA(a) | $-23,672 | $-23,537 | $-22,345 | $-20,480 | $-27,546 |